{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:31Z","timestamp":1793995591284,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12072-022-10438-0","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T06:03:08Z","timestamp":1670220188000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial"],"prefix":"10.1007","volume":"17","author":[{"given":"Apurva","family":"Pande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shvetank","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Khillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saggere Muralikrishna","family":"Shasthry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jagdish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Mondot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e9l","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-5610","authenticated-orcid":false,"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"10438_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/hep.30516","volume":"70","author":"SM Shasthry","year":"2019","unstructured":"Shasthry SM, Sharma MK, Shasthry V, Pande A, Sarin SK. Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial. Hepatology. 2019;70:802\u2013811. https:\/\/doi.org\/10.1002\/hep.30516","journal-title":"Hepatology"},{"key":"10438_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, O\u2019Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255\u2013260. https:\/\/doi.org\/10.1136\/gut.2010.224097","journal-title":"Gut"},{"key":"10438_CR3","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/nejmoa1412278","volume":"372","author":"M Thursz","year":"2015","unstructured":"Thursz M, Richardson P, Allison M, Austin A, Bowers M, Day CP, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619\u20131647. https:\/\/doi.org\/10.1056\/nejmoa1412278","journal-title":"N Engl J Med"},{"key":"10438_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis M, Cassard AM, Wrzosek L, Boschat L, Bruneau A, Ferrere G, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut. 2016;65:830\u2013839. https:\/\/doi.org\/10.1136\/gutjnl-2015-310585","journal-title":"Gut"},{"key":"10438_CR5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology. 2020;71:2050\u20132066. https:\/\/doi.org\/10.1002\/hep.30975","journal-title":"Hepatology"},{"key":"10438_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113:175\u2013194. https:\/\/doi.org\/10.1038\/ajg.2017.469","journal-title":"Am J Gastroenterol"},{"key":"10438_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ni.2608","volume":"14","author":"N Kamada","year":"2013","unstructured":"Kamada N, Chen G, Inohara N, N\u00fa\u00f1ez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14:685\u2013690. https:\/\/doi.org\/10.1038\/ni.2608","journal-title":"Nat Immunol"},{"key":"10438_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","volume":"70","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 2019;70:260\u2013272. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.019","journal-title":"J Hepatol"},{"key":"10438_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335:2\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.04.005","journal-title":"Mol Cell Endocrinol"},{"key":"10438_CR10","unstructured":"Chatham WW. Glucocorticoid effects on the immune system. UpToDate 2022. https:\/\/www.uptodate.com\/contents\/glucocorticoid-effects-on-the-immune-system."},{"key":"10438_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","volume":"152","author":"N Vergis","year":"2017","unstructured":"Vergis N, Atkinson SR, Knapp S, Maurice J, Allison M, Austin A, et al. In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA. Gastroenterology. 2017;152:1068-1077.e4. https:\/\/doi.org\/10.1053\/j.gastro.2016.12.019","journal-title":"Gastroenterology"},{"key":"10438_CR12","first-page":"S201","volume":"75","author":"A Louvet","year":"2022","unstructured":"Louvet A, Labreuche J, Dao T, et al. Combination of amoxicillin\/clavulanate and prednisolone in severe alcoholic hepatitis: results of the randomized controlled trial Antibiocor. J Hepatol. 2022;75:S201\u2013S202","journal-title":"J Hepatol"},{"key":"10438_CR13","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","volume":"156","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, Fagan A, Gavis EA, Kassam Z, Sikaroodi M, Gillivet PM. Long-term outcomes after fecal microbiota transplantation in cirrhosis. Gastroenterology. 2019;156:1921\u20131923. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.033","journal-title":"Gastroenterology"},{"key":"10438_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","volume":"15","author":"CA Philips","year":"2017","unstructured":"Philips CA, Pande A, Shasthry SM, Jamwal KD, Khillan V, Chandel SS, et al. Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study. Clin Gastroenterol Hepatol. 2017;15:600\u2013602. https:\/\/doi.org\/10.1016\/j.cgh.2016.10.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10438_CR15","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.soard.2018.07.021","volume":"14","author":"RV Cortez","year":"2018","unstructured":"Cortez RV, Petry T, Caravatto P, Pess\u00f4a R, Sanabani SS, Martinez MB, et al. Shifts in intestinal microbiota after duodenal exclusion favor glycemic control and weight loss: a randomized controlled trial. Surg Obes Relat Dis. 2018;14:1748\u20131754. https:\/\/doi.org\/10.1016\/j.soard.2018.07.021","journal-title":"Surg Obes Relat Dis"},{"key":"10438_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/hep.31496","volume":"73","author":"JS Bajaj","year":"2021","unstructured":"Bajaj JS, Gavis EA, Fagan A, Wade JB, Thacker LR, Fuchs M, et al. A randomized clinical trial of fecal microbiota transplant for alcohol use disorder. Hepatology. 2021;73:1688\u20131700. https:\/\/doi.org\/10.1002\/hep.31496","journal-title":"Hepatology"},{"key":"10438_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","volume":"16","author":"A Sharma","year":"2022","unstructured":"Sharma A, Roy A, Premkumar M, Verma N, Duseja A, Taneja S, et al. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial. Hepatol Int. 2022;16:433\u2013446. https:\/\/doi.org\/10.1007\/s12072-022-10312-z","journal-title":"Hepatol Int"},{"key":"10438_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150:785\u2013790. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.042","journal-title":"Gastroenterology"},{"key":"10438_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.21607","volume":"45","author":"A Louvet","year":"2007","unstructured":"Louvet A, Naveau S, Abdelnour M, Ramond M-J, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348\u20131354. https:\/\/doi.org\/10.1002\/hep.21607","journal-title":"Hepatology"},{"key":"10438_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00606-19","author":"C Diener","year":"2020","unstructured":"Diener C, Gibbons SM, Resendis-Antonio O. MICOM: Metagenome-scale modeling to infer metabolic interactions in the gut microbiota. MSystems. 2020. https:\/\/doi.org\/10.1128\/mSystems.00606-19","journal-title":"MSystems"},{"key":"10438_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/liv.12939","volume":"36","author":"BS Hmoud","year":"2016","unstructured":"Hmoud BS, Patel K, Bataller R, Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int Off J Int Assoc Study Liver. 2016;36:721\u2013728. https:\/\/doi.org\/10.1111\/liv.12939","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10438_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12866-019-1689-y","volume":"19","author":"OV Goloshchapov","year":"2019","unstructured":"Goloshchapov OV, Olekhnovich EI, Sidorenko SV, Moiseev IS, Kucher MA, Fedorov DE, et al. Long-term impact of fecal transplantation in healthy volunteers. BMC Microbiol. 2019;19:312. https:\/\/doi.org\/10.1186\/s12866-019-1689-y","journal-title":"BMC Microbiol"},{"key":"10438_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12916-016-0698-z","volume":"14","author":"J Jalanka","year":"2016","unstructured":"Jalanka J, Mattila E, Jouhten H, Hartman J, de Vos WM, Arkkila P, et al. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. BMC Med. 2016;14:155. https:\/\/doi.org\/10.1186\/s12916-016-0698-z","journal-title":"BMC Med"},{"key":"10438_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/hep.27489","volume":"61","author":"P Chen","year":"2015","unstructured":"Chen P, St\u00e4rkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology. 2015;61:883\u2013894. https:\/\/doi.org\/10.1002\/hep.27489","journal-title":"Hepatology"},{"key":"10438_CR25","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/jgh.13731","volume":"32","author":"GA Cresci","year":"2017","unstructured":"Cresci GA, Glueck B, McMullen MR, Xin W, Allende D, Nagy LE. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury: Tributyrin and chronic-binge ethanol. J Gastroenterol Hepatol. 2017;32:1587\u20131597. https:\/\/doi.org\/10.1111\/jgh.13731","journal-title":"J Gastroenterol Hepatol"},{"key":"10438_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","volume":"149","author":"C Kelly","year":"2015","unstructured":"Kelly C, Kahn S, Kashyap P. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149:223\u2013237. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.008","journal-title":"Gastroenterology"},{"key":"10438_CR27","doi-asserted-by":"publisher","first-page":"120A","DOI":"10.1002\/hep.32187","volume":"74","author":"S Baweja","year":"2021","unstructured":"Baweja S. Faecal microbial transplant suppresses hepatic and systemic inflammatory responses and gut leakiness in severe alcoholic hepatitis patients. Hepatology. 2021;74:120A. https:\/\/doi.org\/10.1002\/hep.32187","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10438-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10438-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10438-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:46:43Z","timestamp":1675342003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10438-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10438"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10438-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Apurva Pande, Shvetank Sharma, Vikas Khillan, Archana Rastogi, Vinod Arora, Saggere Muralikrishna Shasthry, Rajan Vijayaraghavan, Rakesh Jagdish, Manoj Kumar, Guresh Kumar, Stanislas Mondot, Jo\u00e9l Dore, Shiv K. Sarin declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the appropriate Institutional Ethics Committee and CONSORT guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was taken from all the participants before enrolling the patients in the trial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}